Baltimore Law Firm to Assess Legal Merits of Fosamax Litigation

Share Article

Law firm Ingerman & Horwitz claims that sufferers of osteoporosis may develop complications resulting in "dead jaw", a serious health issue as a result of using Fosamax. The firm announces an interest in pursuing this topic and assessing the merits of a legal case.

Baltimore-based personal injury law firm Ingerman & Horwitz LLP has recently published information on its website as related to Fosamax, a Merck drug approved for those suffering with Osteoporosis.

The law firm claims it has received inquiries from citizens regarding possible side effects related to their use of Fosamax. The firm does not yet have a suit against Merck, but rather is currently investigating the issue to assess the merits of possible case.

This new interest in hearing from Fosamax users fits in with firm's traditional practice areas of personal injury, product liability and medical malpractice. The partners at Ingerman & Horwitz have over 100 years of combined legal experience.

According to an article on CNN Money (, there were 15 cases filed against Merck in relation to Fosamax as of May 9, 2006. The article did not cite case numbers.

Ingerman & Horwitz LLP has published resources on its website at that provide additional fosamax health and legal information including additional side effects and symptoms that individuals have reported. It should be noted that the information published on their site is reported by users and does not necessarily represent a professional medical opinion.

For anyone taking Fosamax, it would be in their best interest to pay careful attention to any unusual reactions until studies can accurate confirm or deny any serious health effects.

More information about Fosamax-related legal rights can be found at or by contacting your doctor or lawyer.

For more information please contact Baltimore, Maryland-based law firm of Ingerman & Horwitz LLP at or 1-800-776-4529.


Share article on social media or email:

View article via:

Pdf Print

Contact Author

Alan Horwitz

Email >
Visit website